DAPAGLIFLOZIN: NEWER MOLECULE FOR TREATMENT OF TYPE 2 DIABETES MELLITUSType 2 diabetes mellitus is a common chronic disease that causes significant morbidity and mortality worldwide. Diabetes results from a combination of increased hepatic glucose product. (2024). International Research Journal of Pharmacy, 2(1), 32-40. https://irjponline.org/index.php/irjp/article/view/1741